Price $32.58 |
Market Cap
2.89B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.16
|
P/S
0.92
|
Dividend %
-
|
|
P/CF
64.3
|
P/FCF
8.7
|
Op. Cash Flow
341.4K
|
FCF
3.7
|
|
Op. Margin
-0.10%
|
Net Margin
-6.90%
|
ROE
-8.80%
|
ROI
0.20%
|
|
ROA
-3.20%
|
EPS Growth
-193.60%
|
Current Ratio
1.1
|
Debt/Equity
135.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Novelion Therapeutics Inc (USA (NVLNF) | $0.74 | - | - | 13.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.94 | - | - | 110.4M | Strong Buy |
| Sanara Medtech Inc (SMTI) | $10.78 | - | - | 39.5M | Strong Buy |
| Five Star Senior Living Inc (FVE) | $4.76 | - | - | 24.4M | Strong Buy |
| Encision Inc (ECIA) | $0.48 | - | - | 5.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
